Bolt Medical Secures $66.4 Million Funding for Groundbreaking Laser Catheter Technology

Bolt Medical, a pioneering company at the forefront of medical technology, has successfully secured $664 million in its latest funding round. This significant capital infusion will bolster their mission to revolutionize treatment options for patients suffering from moderate to severe calcified arterial disease, a condition that poses substantial risks during coronary and peripheral interventional procedures. As the medical community increasingly recognizes the limitations of traditional treatment modalities, Bolt Medical is dedicated to designing and developing innovative laser-based intravenous lithotripsy (IVL) catheters that break down calcium build-up in arteries, facilitating smoother and more effective interventions. The funding will not only accelerate the research and development of their advanced catheter platforms but will also propel the company into pivotal clinical trials across three unique catheter technologies tailored for various arterial vessel beds. With this latest achievement, Bolt Medical is well-positioned to lead the charge in improving patient outcomes and enhancing the quality of care for those battling calcified arterial disease. The company’s forward-thinking approach and cutting-edge technology are set to change the landscape of vascular intervention, and this funding marks a vital step toward bringing their innovative solutions to the forefront of clinical practice. As Bolt Medical continues its journey, stakeholders and the broader medical community eagerly anticipate the transformative impact these groundbreaking devices could have on patient health and recovery.